MN HF3664 | 2023-2024 | 93rd Legislature
Status
Spectrum: Slight Partisan Bill (Democrat 3-1)
Status: Introduced on February 13 2024 - 25% progression
Action: 2024-03-18 - Author added Hemmingsen-Jaeger
Pending: House Health Finance & Policy Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on February 13 2024 - 25% progression
Action: 2024-03-18 - Author added Hemmingsen-Jaeger
Pending: House Health Finance & Policy Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Commissioner of human services authorized to provide separate reimbursement for biological products provided in the inpatient hospital setting as part of cell or gene therapy to treat rare diseases.
Title
Commissioner of human services authorized to provide separate reimbursement for biological products provided in the inpatient hospital setting as part of cell or gene therapy to treat rare diseases.
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2024-03-18 | House | Author added Hemmingsen-Jaeger |
| 2024-03-13 | House | Author added Nadeau |
| 2024-02-26 | House | Author added Reyer |
| 2024-02-13 | House | Introduction and first reading, referred to Health Finance and Policy |
Same As/Similar To
SF4058 (Similar To) 2024-02-22 - Referred to Health and Human Services
